Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia Muhlemann

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Therapeutic Innovation & Regulatory Science|January 31, 2023
Bayesian Clinical TrialsJennifer Clark, Natalia Muhlemann, Alexei Ionan
Therapeutic Innovation & Regulatory Science|April 6, 2023
Correction to: Bayesian Clinical TrialsJennifer Clark, Natalia Muhlemann, Alexei Ionan
Therapeutic Innovation & Regulatory Science|January 3, 2022
Why are not There More Bayesian Clinical Trials? Perceived Barriers and Educational Preferences Among Medical Researchers Involved in Drug Development, Jennifer Clark, Natalia Muhlemann, et al.
European Stroke Journal|July 9, 2020
Improving economic evaluations in stroke: A report from the ESO Health Economics Working GroupDominique A Cadilhac, Joosup Kim, Alastair Wilson, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Therapeutic Innovation & Regulatory Science|January 31, 2023
Bayesian Clinical TrialsJennifer Clark, Natalia Muhlemann, Alexei Ionan
Therapeutic Innovation & Regulatory Science|April 6, 2023
Correction to: Bayesian Clinical TrialsJennifer Clark, Natalia Muhlemann, Alexei Ionan
Therapeutic Innovation & Regulatory Science|January 3, 2022
Why are not There More Bayesian Clinical Trials? Perceived Barriers and Educational Preferences Among Medical Researchers Involved in Drug Development, Jennifer Clark, Natalia Muhlemann, et al.
European Stroke Journal|July 9, 2020
Improving economic evaluations in stroke: A report from the ESO Health Economics Working GroupDominique A Cadilhac, Joosup Kim, Alastair Wilson, et al.
Pageof 1